GH1, growth hormone 1, 2688

N. diseases: 686; N. variants: 27
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 Biomarker group BEFREE Determining the different detection mechanisms, the phenotype of neurosecretion, and neural connections involving glucose-sensitive neurons is essential to understanding the response to hypoglycemia through modulation of food intake, thermogenesis, and activation of sympathetic and parasympathetic branches, inducing glucagon and epinephrine secretion and other hypothalamic-pituitary axis-dependent counterregulatory hormones, such as glucocorticoids and growth hormone. 29796992 2019
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 Biomarker group BEFREE Magnetic resonance spectroscopy may serve as a presurgical predictor of somatostatin analog therapy response in patients with growth hormone-secreting pituitary macroadenomas. 30171531 2019
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 Biomarker group BEFREE It acutely stimulates growth hormone (GH) secretion from the anterior pituitary glands and modulates hypothalamic circuits that control food intake and energy expenditure. 30230184 2018
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 Biomarker group BEFREE Recent advances in our knowledge about dura mater graft- and human pituitary-derived growth hormone-associated CJD patients have revealed that the combination of the infected CJD strain and the PRNP genotype of the patient determines their clinical, neuropathologic, and biochemical features. 29887137 2018
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 Biomarker group BEFREE These results suggest that central administration of ghrelin primarily act on hypothalamic GHRH neurons to stimulate GH release from the pituitary in the tilapia. 29934855 2018
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 Biomarker group BEFREE GnRH1 and GnRH3 were shown to stimulate growth hormone (Gh) release from primary culture of pituitary cells, and to decrease Gh contents in the pituitary of ricefield eels 12 h post injection. 30555419 2018
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 Biomarker group BEFREE We assessed the somatotropic activation, by evaluating growth hormone (GH) gene expression and protein content in the pituitary, as well is GH concentration in the serum. 28993146 2017
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 Biomarker group BEFREE The aim of this study was to evaluate growth hormone and cortisol secretion using the glucagon stimulation test in an elderly population without known hypothalamic-pituitary disease and to correlate growth hormone and cortisol peaks with age (less than or greater than 80 years) and body mass index. 28285384 2017
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 Biomarker group BEFREE Rare Frequency of Mutations in Pituitary Transcription Factor Genes in Combined Pituitary Hormone or Isolated Growth Hormone Deficiencies in Korea. 28332357 2017
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 Biomarker group BEFREE Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years. 26268531 2015
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 Biomarker group BEFREE Locally produced peripheral tissue GH, in contrast to circulating pituitary-derived endocrine GH, has been proposed to be both proapoptotic and prooncogenic. 23940366 2013
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 Biomarker group BEFREE Collectively, these data demonstrate a critical role for neurofibromin in hypothalamic-pituitary axis function and provide further insights into the short stature and GH deficits seen in children with NF1. 18614544 2008
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 Biomarker group BEFREE Because pituitary hormones such as growth hormone (GH), ACTH, and thyroid-stimulating hormone affect body weight and composition, appetite, insulin sensitivity, and lipoprotein metabolism, we investigated whether MCH exerts direct effects on the human pituitary to regulate energy balance using dispersed human fetal pituitaries (21-22 wk gestation) and cultured GH-secreting adenomas. 16603725 2006
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 Biomarker group BEFREE We conclude that low IGF-1 is common in patients with JS and short stature, and that growth hormone status and possibly hypothalamic-pituitary function should be evaluated in this patient population. 15266617 2004
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 Biomarker group BEFREE The demonstration of abnormal endogenous GH secretion may demonstrate an underlying hypothalamic-pituitary dysfunction that results in poor growth. 11335753 2001
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 Biomarker group BEFREE The most frequent of the latter include acquired forms secondary to injections of human cadaveric pituitary-derived growth hormone and the new variant of CJD--probably related to bovine spongiform encephalopathy. 10221164 1999
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 AlteredExpression group BEFREE The transcription factor pituitary-1 (Pit-1) is a homeodomain-containing protein that is expressed mainly in the pituitary, where it drives the expression of growth hormone, prolactin, and thyroid-stimulating hormone beta chain genes. 9828108 1998
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 AlteredExpression group BEFREE The characterization of pathological lesions in several other pituitary-expressed genes that are epistatic to GH1 (POU1F1, PROP1 and GHRHR) has identified additional causes of GH deficiency, the molecular genetics of which are also explored. 9799079 1998
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 Biomarker group BEFREE In conclusion, although somatic gene therapy for GH delivery is beneficial for pituitary dwarfism, it may have adverse metabolic consequences in those with normal hypothalamic-pituitary functions, and the female mice were more severely affected than males. 8825869 1996
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 Biomarker group BEFREE These results indicate that PSF protein can repress CS-A promoter activity in a tissue-specific manner in vitro and provide a possible mechanism by which expression of placental members of the GH family are inhibited in the pituitary in vivo. 8473291 1993
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 AlteredExpression group BEFREE The specific expression of growth hormone (GH) in the somatotrophic cells of the anterior pituitary is largely attributable to a short promoter in the 5' flanking region of the GH gene. 2574416 1990
CUI: C0032002
Disease: Pituitary Diseases
Pituitary Diseases
0.100 Biomarker group BEFREE A complete hormonal evaluation in one of the patients showed abnormal growth hormone (GH) and gonadotropin responses to different stimuli, findings suggestive of a disorder of hypothalamic-pituitary regulation. 2502012 1989